Psilocybin Scientific Papers, AEDMP, 2014

Psilocybin Scientific Papers

AEDMP – Asociación para el Estudio y la Divulgación de la Medicina Psicodélica

Research conducted by: Fco. Miguel Ríos & Genís Oña – 2014 –

Asociación para el Estudio y la Divulgación de la Medicina Psicodélica. Castellarnau, 11 2º 1ª 43004 Tarragona Spain Tel. 675 55 33 44 Email: medicina.psicodelica@hotmail.com www.medicinapsicodelica.org

Content _____________________________________ 1.

What is Psilocybin? 2.

Scientific papers about Psilocybin arranged chronologically (1959-2014) –

A. Hofmann (1959). Chemical Aspects of Psilocybin, the Psychotropic Principle from the Mexican Fungus, Psilocybe Mexicana Heim –

S. Malitz et al. (1960). Some Observations on Psilocybin, a New Hallucinogen, in Volunteer Subjects –

L. E. Hollister (1961). Clinical, Biochemical and Psychologic Effects of Psilocybin –

M. Rinkel et al. (1961). Personality Patterns and Reaction to Psilocybine –

T. Leary et al. (1963). Reactions to Psilocybin Administered in a Supportive Environment –

J. Delay et al. (1963). The Therapeutic Implications of Psilocybine –

J. S. Da Fonseca et al. (1965). Evoked Potentials and Visual Information Processing Under the Action of Psilocybin in the Cat –

J. R. Flores (1965). Psicosíndrome Experimental con Psilocibina –

M. H. Keeler (1965). The Effects of Psilocybin on a Test of After-image Perception –

R. Metzner et al. (1965). The Relation of Expectation and Mood to Psilocybin Reactions: A Questionnaire Study –

R. Fischer & D. Warshay (1968). Psilocybin-induced Autonomic, Perceptual, and Behavioral Change –

O. Tosi et al. (1968). Quantitative Measurement of Time Contraction Induced by Psilocybin –

B. Clark (1968). Some Early Observations on the Use of Psilocybin in Psychiatric Patients –

R. Fischer et al. (1969). Effects of the Psychodysleptic Drug Psilocybin on Visual Perception. Changes in Brightness Preference –

P. H. Gwynne et al. (1969). Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion –

K. Thatcher et al. (1971). An Electroencephalographic Analysis of Personality-dependent Performance Under Psilocybin –

R. M. Hill & R. Fischer (1973). Induction and Extinction of Psilocybin Induced Transformations of Visual Space –

C. Martindale & R. Fischer (1977). The Effects of Psilocybin on Primary Process Content in Language –

N. R. Peden et al. (1981). Clinical Toxicology of “Magic Mushrooms” Ingestion –

J. Koerner & J. B. Appel (1982). Psilocybin as a Discriminative Stimulus: Lack of Specificity in an

Animal Behavior Model for “Hallucinogens”

R. Doblin (1991). Pahnke’s “Good Friday Experiment”: A Long-term Follow-up and Methodological Critique –

M. Spitzer et al. (1996). Increased Activation of Indirect Semantic Associations Under Psilocybin –

F. X. Vollenweider et al. (1997). Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis –

R. Doblin (1998). Dr. Leary’s Concord Prison Experiment: A 34-Year Follow-up Study –

F. X. Vollenweider et al. (1998). Psilocybin Induces Schizophrenia-like Psychosis in Humans Via a Serotonin-2 Agonist Action –

K. S. Borowiak et al. (1998). Psilocybin Mushroom ( Psilocybe semilanceata ) Intoxication with Myocardial Infarction –

E. Gouzoulis-Mayfrank et al. (1999). Effects of the Hallucinogen Psilocybin on Habituation and Prepulse Inhibition of the Startle Reflex in Humans –

G. Sticht & H. Käferstein (2000). Detection of Psilocin in Body Fluids –

T. H. Lim et al. (2002). A Fatal Case of “Magic Mushroom” Ingestion in a Heart Transplant Recipient –

E. Gouzoulis-Mayfrank et al. (2002). Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans –

T. Passie et al. (2002). The Pharmacology of Psilocybin –

F. Hasler et al. (2004). Acute Psychological and Physiological Effects of Psilocybin in Healthy Humans: A Double-blind, Placebo-controlled Dose-effect Study –

O. L. Carter et al. (2004). Psilocybin Impairs High-level but not Low-level Motion Perception –

M. Espiard et al. (2005). Hallucinogen Persisting Perception Disorder After Psilocybin Consumption: A Case Study –

O. L. Carter et al. (2005). Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT 2A and 5-HT 1A Agonist Psilocybin –

O. L. Carter et al. (2005). Using Psilocybin to Investigate the Relationship Between Attention, Working Memory, and the Serotonin 1A and 2A Receptors –

R. R. Griffiths et al. (2006). Psilocybin can Occasion Mystical-type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance –

R. A. Sewell et al. (2006). Response of Cluster Headache to Psilocybin and LSD –

M. Wittmann et al. (2007). Effects of Psilocybin on Time Perception and Temporal Control of Behavior in Humans –

O. L. Carter et al. (2007). Psilocybin Links Binocular Rivalry Switch Rate to Attention and Subjective Arousal Levels in Humans –

C. S. Grob (2007). The Use of Psilocybin in Patients with Advanced Cancer and Existential Anxiety –

J. Wackermann et al. (2008). Effects of Varied Doses of Psilocybin on Time Interval Reproduction in Human Subjects –

R. R. Griffiths et al. (2008). Mystical-type Experiences Occasioned by Psilocybin Mediate the Attribution of Personal Meaning and Spiritual Significance 14 Months Later –

C. S. Grob et al. (2010). Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-stage Cancer –

R. L. Carhart-Harris et al. (2010). The Administration of Psilocybin to Healthy, Hallucinogen experienced Volunteers in a Mock-functional Magnetic Resonance Imaging Environment : A Preliminary Investigation of Tolerability –

E. Studerus et al. (2011). Acute, Subacute and Long-term Subjective Effects of Psilocybin in Healthy Humans : A Pooled Analysis of Experimental Studies –

J. van Amsterdam et al. (2011). Harm Potential of Magic Mushroom Use : A Review –

K. A. MacLean et al. (2011). Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness –

R. R. Griffiths et al. (2011). Psilocybin Occasioned Mystical-type Experiences: Immediate and Persisting Dose-related Effects –

B. B. Quednow et al. (2011). Psilocybin-induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers –

R. L. Carhart-Harris et al. (2012). Implications for Psychedelic-assisted Psychotherapy: Functional Magnetic Resonance Imaging Study with Psilocybin –

R. L. Carhart-Harris et al. (2012). Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin –

E. Studerus et al. (2012). Prediction of Psilocybin Response in Healthy Volunteers –

M. Kometer et al. (2012). Psilocybin Biases Facial Recognition, Goal-directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors –

M. W. Johnson et al. (2012). Psilocybin Dose-dependently Causes Delayed, Transient Headaches in Healthy Volunteers –

B. J. Catlow et al. (2013). Effects of Psilocybin on Hippocampal Neurogenesis and Extinction of Trace Fear Conditioning –

R. L. Carhart-Harris et al. (2013). Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis –

C. Cummins & J. Lyke (2013). Peak Experiences of Psilocybin Users and Non-users –

F. Tyls et al. (2014). Psilocybin

–

Summary of Knowledge and New Perspectives

What is Psilocybin ?

Psilocybin is a naturally occurring compound categorized as a psychoactive tryptamine that is found in some species of mushrooms. These mushrooms have been used for thousands of years by various cultures in order to achieve transcendent states of consciousness. In the 1960s, psilocybin was widely used in the experimental research of mental disorders and even in psychotherapy due to its therapeutic potential. However, psilocybin spread amongst the general public and became a popular recreational drug. Consequently, psilocybin was classed as a schedule I drug in 1970 and all human experiments were gradually discontinued. Since the 1990s, psychedelic research is being revived, and the properties of this substance have been rediscovered, becoming one of the most used psychedelics in human studies due to its safety.

(…)

AEDMP_Bibliography_of_Psilocybin_2014

Categories : Bibliographies Pharmacologie Ressources Documentaires Substances psychédéliques et therapeutique